Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALKEM LABORATORIES BIOCON /
ALKEM LABORATORIES
 
P/E (TTM) x 36.5 32.8 111.3% View Chart
P/BV x 4.1 4.3 96.3% View Chart
Dividend Yield % 0.2 1.1 16.1%  

Financials

 BIOCON    ALKEM LABORATORIES
EQUITY SHARE DATA
    BIOCON
Mar-22
ALKEM LABORATORIES
Mar-22
BIOCON /
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4244,068 10.4%   
Low Rs3152,671 11.8%   
Sales per share (Unadj.) Rs68.2889.4 7.7%  
Earnings per share (Unadj.) Rs8.2140.5 5.8%  
Cash flow per share (Unadj.) Rs14.9166.0 9.0%  
Dividends per share (Unadj.) Rs0.5034.00 1.5%  
Avg Dividend yield %0.11.0 13.4%  
Book value per share (Unadj.) Rs68.5722.4 9.5%  
Shares outstanding (eoy) m1,200.60119.57 1,004.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.43.8 143.1%   
Avg P/E ratio x45.324.0 189.1%  
P/CF ratio (eoy) x24.720.3 121.9%  
Price / Book Value ratio x5.44.7 115.6%  
Dividend payout %6.124.2 25.4%   
Avg Mkt Cap Rs m443,622402,868 110.1%   
No. of employees `000NANA-   
Total wages/salary Rs m18,80119,627 95.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,840106,342 77.0%  
Other income Rs m6,8911,627 423.7%   
Total revenues Rs m88,731107,968 82.2%   
Gross profit Rs m13,82720,380 67.8%  
Depreciation Rs m8,1423,040 267.9%   
Interest Rs m676524 129.1%   
Profit before tax Rs m11,90018,443 64.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1151,640 129.0%   
Profit after tax Rs m9,78516,803 58.2%  
Gross profit margin %16.919.2 88.2%  
Effective tax rate %17.88.9 199.9%   
Net profit margin %12.015.8 75.7%  
BALANCE SHEET DATA
Current assets Rs m83,82384,354 99.4%   
Current liabilities Rs m38,28048,053 79.7%   
Net working cap to sales %55.634.1 163.0%  
Current ratio x2.21.8 124.7%  
Inventory Days Days10142 239.8%  
Debtors Days Days9265 141.9%  
Net fixed assets Rs m117,18443,245 271.0%   
Share capital Rs m6,003239 2,510.7%   
"Free" reserves Rs m76,28186,134 88.6%   
Net worth Rs m82,28486,373 95.3%   
Long term debt Rs m39,98594 42,627.9%   
Total assets Rs m201,007127,599 157.5%  
Interest coverage x18.636.2 51.4%   
Debt to equity ratio x0.50 44,746.3%  
Sales to assets ratio x0.40.8 48.9%   
Return on assets %5.213.6 38.3%  
Return on equity %11.919.5 61.1%  
Return on capital %10.321.9 46.9%  
Exports to sales %018.7 0.0%   
Imports to sales %7.80-   
Exports (fob) Rs mNA19,924 0.0%   
Imports (cif) Rs m6,360NA-   
Fx inflow Rs m8,88519,924 44.6%   
Fx outflow Rs m6,3603,911 162.6%   
Net fx Rs m2,52516,013 15.8%   
CASH FLOW
From Operations Rs m11,76611,110 105.9%  
From Investments Rs m-16,991-14,351 118.4%  
From Financial Activity Rs m2,4213,796 63.8%  
Net Cashflow Rs m-2,433580 -419.8%  

Share Holding

Indian Promoters % 39.7 57.2 69.4%  
Foreign collaborators % 21.0 0.0 -  
Indian inst/Mut Fund % 23.6 20.2 116.6%  
FIIs % 15.8 4.5 354.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 42.8 91.9%  
Shareholders   369,816 79,721 463.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on Biocon vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs ALKEM LABORATORIES Share Price Performance

Period Biocon ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -0.32% 0.34% 0.23%
1-Month 3.17% -1.10% 0.36%
1-Year -22.80% -12.29% -6.87%
3-Year CAGR -0.27% 14.98% 20.16%
5-Year CAGR -8.24% 9.37% 11.07%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of ALKEM LABORATORIES the stake stands at 57.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

ALKEM LABORATORIES paid Rs 34.0, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Biocon, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.